- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
New oncologist joining Memorial Sloan-Kettering: IBM's Watson
IBM's supercomputer and Jeopardy! champion 'Watson' is not only being used in the finance and insurance industries, it is now officially going into the medical field.
At a joint press conference, IBM and Memorial Sloan-Kettering Cancer Center in the New York announced that Watson will be used at Memorial to help make the best diagnosis and offer the most up-to-date treatment recommendations, thanks to its ability to process stores and stores of information in seconds.
“The combination of transformational technologies found in Watson with our cancer analytics and decision-making process has the potential to revolutionize the accessibility of information for the treatment of cancer in communities across the country and around the world,” said Sloan-Kettering CEO Craig B. Thompson. “We also expect tremendous new research opportunities to emerge from this collaboration.”